A group of Irish women is considering launching a legal action against the makers of a drug that has been described as the 'silent thalidomide'.
DES, a synthetic oestrogen, was prescribed to millions of women worldwide in the 1950s, '60s and '70s to prevent miscarriages and birth complications. However, new research from the American National Cancer Institute has revealed that women whose mothers took the drug are twice as likely to develop breast cancer....
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team